Accenture Invests in SpiderOak to Elevate Satellite Communications Security in Space
NEW YORK; May 18, 2023 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in SpiderOak, a leader in zero-trust cybersecurity and resiliency solutions for next generation space systems.
May 18, 2023
Accenture Invests in Stardog to Help Companies Optimize their Data Insights and Value
NEW YORK; May 10, 2023 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Stardog, a leading enterprise knowledge graph platform enabling organizations to do more with, and achieve greater value from, their data in this age of generative artificial intelligence (AI).
May 10, 2023
Accenture and Cervest Collaborate to Bring Innovative Solutions to Clients Seeking Resilience Amid Increased Climate Risk
NEW YORK and LONDON; May 4, 2023 – Accenture (NYSE: ACN) through its Accenture Ventures Project Spotlight initiative, has entered into a collaboration agreement with Cervest, an AI-powered climate intelligence (CI) platform, that will expand Accenture’s capabilities to deliver on-demand access to historical, current and predictive views of combined climate risks to assess and address asset and portfolio vulnerabilities for clients across industries.
May 04, 2023
Accenture Invests in Virtonomy to Help Medical Technology Companies Use Digital Twin Technology to Accelerate Time to Market for Medical Devices
MUNICH and NEW YORK; April 12, 2023 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Virtonomy, a provider of data-driven simulations that use existing patient data and digital twin technology to bring life-saving medical devices to market more quickly. Accenture’s investment will help Virtonomy further extend its capabilities to medical technology (MedTech) companies across the globe and power the future of medical device design.
April 12, 2023
Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
NEW YORK; Feb. 16 , 2023 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Ocean Genomics, a technology and AI company that has developed advanced computational platforms to assist biopharma companies to discover and develop more effective diagnostics and therapeutics.
February 16, 2023
Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
NEW YORK; Feb. 7, 2023 – Accenture (NYSE: ACN) has made a strategic investment through Accenture Ventures in Looking Glass Factory, a leading hologram company. Looking Glass, with headquarters in Brooklyn, New York and additional operations in Hong Kong, has developed an end-to-end holographic platform, with a lineup of displays that can show content in life-like 3D, without requiring the use of headsets or head-tracking.
February 07, 2023